- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 13, 2024 | 414.45M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $420.26K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $699.35K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $1.32M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $1.62M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $1.54M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $1.86M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $1.45M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $1.66M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.85M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $2.09M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 414.45M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $4.03K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$39.91K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $444.18K |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $452.59K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Net Income | Q1 2024 · Mar 31, 2023 | −$8.41K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$1.49K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $503.26K |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $129K |